ERGO (Entia Biosciences) Total Equity: $-1.97 Mil (As of Dec. 2016)


What is Entia Biosciences Total Equity?

Entia Biosciences ERGO Total Equity is $-1.97 Mil as of Dec. 2016.

Entia Biosciences's total equity for the quarter that ended in Dec. 2016 was $-1.97 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Entia Biosciences Total Equity Historical Data

* Premium members only.

The historical data trend for Entia Biosciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entia Biosciences Total Equity Chart

Entia Biosciences Annual Data
Trend Jul07 Jul08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.65 -0.95 -0.12 -0.79 -1.97

Entia Biosciences Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.79 -1.03 -1.39 -1.64 -1.97

Entia Biosciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Entia Biosciences's Total Equity for the fiscal year that ended in Dec. 2016 is calculated as

Total Equity=Total Assets(Q: Dec. 2016 )-Total Liabilities(Q: Dec. 2016 )
=0.439-2.406
=-1.97

Entia Biosciences's Total Equity for the quarter that ended in Dec. 2016 is calculated as

Total Equity=Total Assets(Q: Dec. 2016 )-Total Liabilities(Q: Dec. 2016 )
=0.439-2.406
=-1.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-1.97 Mil mean?
Entia Biosciences (ERGO) has a Total Equity of $-1.97 Mil as of Dec. 2016. The total amount of equity as record on a company's balance sheet. View historical data for Entia Biosciences and its competitors.
Is Entia Biosciences' Total Equity too high?
Entia Biosciences' current Total Equity is $-1.97 Mil.
How does Entia Biosciences' Total Equity compare to OBMP and NSPX?
Entia Biosciences' Total Equity of $-1.97 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Entia Biosciences and its competitors. Entia Biosciences's current Total Equity is $-1.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entia Biosciences stock overvalued right now?
Entia Biosciences (ERGO) has a current Total Equity of $-1.97 Mil. The current Total Equity is $-1.97 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Entia Biosciences (ERGO), the current Total Equity is $-1.97 Mil as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entia Biosciences Business Description

Address 13565 South West Tualatin-Sherwood Road, Suite 800, Sherwood, OR, USA, 97140
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.